在进行氟尿嘧啶化疗前，给予患者检测二氢嘧啶脱氢酶（DPD）缺乏症的选择权。
Give Patients the Choice to Test for DPD Deficiency Before Fluoropyrimidine Chemotherapy.
作者信息
Surprenant Ken, Murray Lindsay, Merritt Karen, Hopkins Maria, McIntyre Joanne
机构信息
Ken Surprenant, MA, Advocates for Universal DPD/DPYD Testing, Battle Creek, MI; Lindsay Murray, HS, Advocates for Universal DPD/DPYD Testing, Andover, MA; Karen Merritt, BS, Advocates for Universal DPD/DPYD Testing, Chelan, WA; Maria Hopkins, BS, Advocates for Universal DPD/DPYD Testing, Battle Creek, MI; and Joanne McIntyre, AA, Advocates for Universal DPD/DPYD Testing, Portland, OR.
出版信息
JCO Oncol Pract. 2025 Feb;21(2):264-265. doi: 10.1200/OP.24.00443. Epub 2024 Dec 3.
PMID:39626133
Abstract
Patients, not physicians, should decide if DPYD screening is right for them before FU/Xeloda chemotherapy.
摘要
在进行氟尿嘧啶/希罗达化疗之前，应由患者而非医生决定是否适合进行二氢嘧啶脱氢酶（DPYD）筛查。
Zotero 插件